A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia

Clinical trial NCT05502367 · TERMINATED

Trial details

NCT number: NCT05502367
Sponsor: Antiva Biosciences
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia

Start date: 2022-09-10
Primary completion: 2025-10-27
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.